San Mateo, CA, United States of America

Yvonne M Chen

USPTO Granted Patents = 20 

 

Average Co-Inventor Count = 6.1

ph-index = 9

Forward Citations = 254(Granted Patents)


Company Filing History:


Years Active: 2003-2024

Loading Chart...
Loading Chart...
20 patents (USPTO):Explore Patents

Title: Yvonne M Chen: Innovator in Biotherapeutics

Introduction

Yvonne M Chen, based in San Mateo, CA, is a prominent figure in the field of biotherapeutics, holding an impressive portfolio of 20 patents. Chen's innovative work primarily focuses on advanced antibody therapies aimed at treating hematopoietic tumors and improving immunological responses in cancer patients.

Latest Patents

Among Chen's latest patents are pivotal breakthroughs in antibody technology. One notable invention is the "Humanized anti-CD79B antibodies and immunoconjugates and methods of use," which provides compositions essential for the treatment of hematopoietic tumors in mammals. Another significant patent is for "Anti-CD8 antibodies and uses thereof," which includes antibodies that bind to human CD8 without activating or inhibiting CD8 T cells. This patent details approaches for detecting CD8 T cells, monitoring disease progress, and tracking treatment efficacy in cancer patients.

Career Highlights

Yvonne Chen has had a significant impact through her roles at leading companies in the pharmaceutical industry, notably Genentech, Inc. Her innovative contributions have been instrumental in advancing cancer treatments and optimizing therapeutic methodologies.

Collaborations

Throughout her career, Chen has collaborated with notable professionals in her field, including Mark S. Dennis and Kristi Elkins, fostering a shared commitment to innovation and research in biotherapeutics. These collaborations underscore her dedication to advancing healthcare solutions through teamwork and shared expertise.

Conclusion

Yvonne M Chen exemplifies the spirit of innovation in biotherapeutics with a focus on antibody technologies. Her extensive patent portfolio reflects her commitment to developing treatments that address critical challenges in cancer therapy. As she continues her work, Chen remains a pivotal figure in the quest for effective medical innovations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…